Tags

Type your tag names separated by a space and hit enter

Persistence of primary MALT lymphoma of the urinary bladder after rituximab with CHOP chemotherapy and radiotherapy.
In Vivo. 2013 Jul-Aug; 27(4):545-9.V

Abstract

We present a case of a patient with primary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the urinary bladder that persisted after chemotherapy, immunotherapy and radiotherapy.

CASE REPORT

A 48-year-old male underwent a routine ultrasound examination. A tumour mass in the urinary bladder was found and a transurethral biopsy was performed. Pathohistological examination revealed MALT lymphoma. Results of computed tomographic scan, positron emission tomography scan and bone marrow biopsy defined the tumour as primary malignant lymphoma of the urinary bladder. The patient received eight cycles of chemo-immunotherapy (CHOP) and radiotherapy. Five months after therapy, there is a partial radiological remission, but with metabolic progression of the tumour. To our knowledge, this is the first case of MALT lymphoma of the urinary bladder with chemo-immunotherapy and radiotherapy resistance.

Authors+Show Affiliations

Department of Pathology, Dubrava University Hospital, Avenija Gojka Šuška 6, 10000 Zagreb, Croatia. jasnabacalja@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

23812229

Citation

Bacalja, Jasna, et al. "Persistence of Primary MALT Lymphoma of the Urinary Bladder After Rituximab With CHOP Chemotherapy and Radiotherapy." In Vivo (Athens, Greece), vol. 27, no. 4, 2013, pp. 545-9.
Bacalja J, Ulamec M, Rako D, et al. Persistence of primary MALT lymphoma of the urinary bladder after rituximab with CHOP chemotherapy and radiotherapy. In Vivo. 2013;27(4):545-9.
Bacalja, J., Ulamec, M., Rako, D., Bošković, L., Trnski, D., Vrdoljak, E., & Krušlin, B. (2013). Persistence of primary MALT lymphoma of the urinary bladder after rituximab with CHOP chemotherapy and radiotherapy. In Vivo (Athens, Greece), 27(4), 545-9.
Bacalja J, et al. Persistence of Primary MALT Lymphoma of the Urinary Bladder After Rituximab With CHOP Chemotherapy and Radiotherapy. In Vivo. 2013 Jul-Aug;27(4):545-9. PubMed PMID: 23812229.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Persistence of primary MALT lymphoma of the urinary bladder after rituximab with CHOP chemotherapy and radiotherapy. AU - Bacalja,Jasna, AU - Ulamec,Monika, AU - Rako,Duje, AU - Bošković,Lidija, AU - Trnski,Davor, AU - Vrdoljak,Eduard, AU - Krušlin,Božo, PY - 2013/7/2/entrez PY - 2013/7/3/pubmed PY - 2014/1/31/medline KW - CHOP KW - MALT lymphoma KW - chemotherapy KW - rituximab KW - urinary bladder SP - 545 EP - 9 JF - In vivo (Athens, Greece) JO - In Vivo VL - 27 IS - 4 N2 - UNLABELLED: We present a case of a patient with primary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the urinary bladder that persisted after chemotherapy, immunotherapy and radiotherapy. CASE REPORT: A 48-year-old male underwent a routine ultrasound examination. A tumour mass in the urinary bladder was found and a transurethral biopsy was performed. Pathohistological examination revealed MALT lymphoma. Results of computed tomographic scan, positron emission tomography scan and bone marrow biopsy defined the tumour as primary malignant lymphoma of the urinary bladder. The patient received eight cycles of chemo-immunotherapy (CHOP) and radiotherapy. Five months after therapy, there is a partial radiological remission, but with metabolic progression of the tumour. To our knowledge, this is the first case of MALT lymphoma of the urinary bladder with chemo-immunotherapy and radiotherapy resistance. SN - 1791-7549 UR - https://www.unboundmedicine.com/medline/citation/23812229/Persistence_of_primary_MALT_lymphoma_of_the_urinary_bladder_after_rituximab_with_CHOP_chemotherapy_and_radiotherapy_ L2 - http://iv.iiarjournals.org/cgi/pmidlookup?view=long&pmid=23812229 DB - PRIME DP - Unbound Medicine ER -